
Joseph Ali
· Associate Director for Global Programs; Associate ProfessorJohns Hopkins University · Ophthalmology
Active 1973–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Joseph Ali, JD, is an Associate Professor at the Johns Hopkins Berman Institute of Bioethics and serves as the Associate Director for Global Programs. His research and teaching engage a range of challenges in domestic and global health ethics, including empirical and normative work in U.S. and international research ethics. He focuses on projects that address the implications of emerging global mobile and digital technologies in health research, public health programs, and disease surveillance, with particular interest in how values are expressed, represented, prioritized, preserved, and influenced in the context of digital technologies. As part of his role, Ali works with colleagues at Johns Hopkins University and internationally to develop multidisciplinary research, training, and service partnerships in bioethics. He is committed to supporting the capacity of scholars from resource-constrained countries to lead bioethics research, teaching, and practice on issues of local importance. Ali has been involved in establishing and operating NIH Fogarty-funded bioethics programs in various countries, including Uganda, Ethiopia, Zambia, Botswana, and Malaysia. He also co-leads the Wellcome-funded Oxford-Johns Hopkins Global Infectious Disease Ethics (GLIDE) Collaborative, which addresses emerging ethical issues related to infectious diseases. His service includes membership on the Johns Hopkins Bloomberg School of Public Health Institutional Review Board and previous…
Research topics
- Computer Science
- Political Science
- Medicine
- Sociology
- Economics
- Data Mining
- Operations management
- Data science
- Business
- Medical emergency
Selected publications
Building trust while influencing online COVID-19 content in the social media world
The Lancet Digital Health · 2020 · 362 citations
With more than two million cases globally, the coronavirus disease 2019 (COVID-19) pandemic has resulted in unprecedented disruption to human society. Leaders from around the world have escalated from states of reluctant acceptance to states of emergency. Unlike historical pandemics, such as the 1918 H1N1 pandemic, COVID-19 is spreading across a highly connected world, in which virtually all individuals are linked to each other through the mobile phone in their pockets. Because of strict physica…
Ensuring trustworthy use of artificial intelligence and big data analytics in health insurance
Bulletin of the World Health Organization · 2020 · 77 citations
Technological advances in big data (large amounts of highly varied data from many different sources that may be processed rapidly), data sciences and artificial intelligence can improve health-system functions and promote personalized care and public good. However, these technologies will not replace the fundamental components of the health system, such as ethical leadership and governance, or avoid the need for a robust ethical and regulatory environment. In this paper, we discuss what a robust…
The Lancet · 2022 · 71 citations
BACKGROUND: The 2015 Lancet Commission on global surgery identified surgery and anaesthesia as indispensable parts of holistic health-care systems. However, COVID-19 exposed the fragility of planned surgical services around the world, which have also been neglected in pandemic recovery planning. This study aimed to develop and validate a novel index to support local elective surgical system strengthening and address growing backlogs. METHODS: First, we performed an international consultation thr…
BMC Medical Ethics · 2024-04-18 · 47 citations
articleOpen accessBACKGROUND: The ethical governance of Artificial Intelligence (AI) in health care and public health continues to be an urgent issue for attention in policy, research, and practice. In this paper we report on central themes related to challenges and strategies for promoting ethics in research involving AI in global health, arising from the Global Forum on Bioethics in Research (GFBR), held in Cape Town, South Africa in November 2022. METHODS: The GFBR is an annual meeting organized by the World H…
Ethical considerations for sharing aggregate results from pragmatic clinical trials
Clinical Trials · 2024-11-25 · 3 citations
articleOpen accessA growing literature has explored the ethical obligations and current practices related to sharing aggregate results with research participants. However, no prior work has examined these issues in the context of pragmatic clinical trials. Several characteristics of pragmatic clinical trials may complicate both the ethics and the logistics of sharing aggregate results. Among these characteristics include that pragmatic clinical trials may affect the rights, welfare, and interests of not only pati…
Recent grants
Frequent coauthors
- 98 shared
Adnan A. Hyder
Milken Institute
- 55 shared
George Pariyo
Johns Hopkins University
- 52 shared
Nancy E. Kass
Johns Hopkins University
- 49 shared
Dustin G. Gibson
Johns Hopkins University
- 43 shared
Alain Labrique
Johns Hopkins University
- 29 shared
Jeremy Sugarman
- 28 shared
Bartolomeu Nascimento
Fundação Getulio Vargas
- 27 shared
Heba F. Taha
Awards & honors
- Bioethics and New Narratives Award
Similar researchers at Johns Hopkins University
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Joseph Ali
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
